Longteng methylene dioxymethamphetamine (ecstasy) in vitro reagent group
Taiwan·Risk Class 2·Longteng Biotechnology Co., Ltd. new market factory·Registered Feb 24, 2020 – Feb 24, 2030Active- Analysis ID
- 8acbd230e0707defdb5e1fd75008c200
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Longteng Biotechnology Co., Ltd. new market factory
- Intended Use
- Qualitative detection of methylenedioxymethamphetamine (ecstasy) and its metabolites in human urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3610 Methamphetamine testing system
- Import Information
- Domestic
- Registration Date
- Feb 24, 2020
- Expiry Date
- Feb 24, 2030
Top companies providing products similar to "Longteng methylene dioxymethamphetamine (ecstasy) in vitro reagent group"
Recently registered similar products
Access comprehensive regulatory information for Longteng methylene dioxymethamphetamine (ecstasy) in vitro reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8acbd230e0707defdb5e1fd75008c200 and manufactured by Longteng Biotechnology Co., Ltd. new market factory. The authorized representative in Taiwan is Longteng Biotechnology Co., Ltd. new market factory.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including The first factory of Longteng Biotechnology Co., Ltd, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.